my CGC
< Back to results
 
OncoRisk Expanded (NGS panel for 89 genes, including CNV analysis)
AIP, ALK, APC, ATM, BAP1, BLM, BMPR1A, BRCA1, BRCA2, BRIP1, BUB1B, CDC73, CDH1, CDK4, CDKN1C, CDKN2A, CEBPA, CEP57, CHEK2, CYLD, DDB2, DICER1, DIS3L2, EPCAM, ERCC2, ERCC3, ERCC4, ERCC5, EXT1, EXT2, EZH2, FANCA, FANCB, FANCC, FANCD2, FANCE, FANCF, FANCG, F
Request Now


Methodology

NGS


Specimen Requirements


Descriptive Volume /
Concentration 1
Container Transport
temperature
Sample
viability (days) 2
DNA ≥ 100 µL [50 ng/µL] Eppendorf Safe-lock Room temp. n/a
Peripheral blood ≥ 3 mL EDTA Room temp. 5
1 When it is not possible to collect the minimum volume for the test, please contact CGC Genetics
2 Maximum shipping time to ensure sample quality

Turnaround Time (Days)

- 45

Specialties

- Oncology


CGC Reference

- 3809




Associated Tests


OncoRisk (NGS panel for 48 genes, including CNV analysis)
Thrombocytopenia and inherited bone marrow failure (WES based NGS panel of 109 genes, including CNV analysis)
Breast and ovary cancer (NGS panel for 26 genes, including CNV analysis)
Fanconi anemia (NGS panel for 15 genes, including CNV analysis)
Limb reduction defects (WES based NGS panel of 143 genes, including CNV analysis)